Old Web
English
Sign In
Acemap
>
authorDetail
>
U. Papendick
U. Papendick
Boehringer Ingelheim
Multicenter trial
Medroxyprogesterone acetate
Cancer
Immunology
Combination therapy
3
Papers
81
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate
1988
Journal of Cancer Research and Clinical Oncology
Franz Porzsolt
D. Messerer
R. Hautmann
A. Gottwald
H. Sparwasser
K. Stockamp
W. Aulitzky
J. G. Moormann
K. Schumacher
H. Rasche
U. Papendick
W. Schreml
Show All
Source
Cite
Save
Citations (36)
Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate: a randomized multicenter trial
1988
Journal of Cancer Research and Clinical Oncology
Franz Porzsolt
D. Messerer
R. Hautmann
A. Gottwald
H. Sparwasser
K. Stockamp
W. Aulitzky
J. G. Moormann
K. Schumacher
H. Rasche
U. Papendick
W. Schreml
Show All
Source
Cite
Save
Citations (45)
Combination therapy of low dose alfa-interferon and medroxyprogesterone acetate in metastatic renal cell cancer. A randomized multicenter trial
1987
Journal of Steroid Biochemistry
Franz Porzsolt
D. Messerer
R. Hautmann
A. Gottwald
H. Sparwasser
K. Stockamp
W. Aulitzky
J.G. Moormam
K. Schumacher
H. Rasche
U. Papendick
W. Schreml
Show All
Source
Cite
Save
Citations (0)
1